http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101254244-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1841 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-495 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2010-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101254244-B1 |
| titleOfInvention | A composition for the prevention or treatment of cell damage by radiation exposure or irradiation containing TSF-β1 as an active ingredient |
| abstract | The present invention relates to a composition for the prevention or treatment of cell damage by radiation exposure or irradiation containing TGF-β1 as an active ingredient, the TGF-β1 not only reduces DNA damage by radiation exposure or irradiation, As it has a protective effect against radiation exposure or irradiation, which can restore DNA, the composition containing TGF-β1 as an active ingredient prevents damage to normal cells during radiation treatment of epithelial cell-derived cancer diseases such as skin cancer and cervical cancer. It can be usefully used as a pharmaceutical or health food which can be prevented. |
| priorityDate | 2010-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.